Your browser doesn't support javascript.
loading
Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies.
Wang, Joshua W; Matsui, Ken; Pan, Yuanji; Kwak, Kihyuck; Peng, Shiwen; Kemp, Troy; Pinto, Ligia; Roden, Richard B S.
Afiliação
  • Wang JW; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland.
  • Matsui K; These authors contributed equally to this work.
  • Pan Y; Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Kwak K; These authors contributed equally to this work.
  • Peng S; Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Kemp T; Department of Pathology, The Johns Hopkins University, Baltimore, Maryland.
  • Pinto L; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland.
  • Roden RB; Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Curr Protoc Microbiol ; 38: 14B.5.1-26, 2015 Aug 03.
Article em En | MEDLINE | ID: mdl-26237105
Immunization with Human Papillomavirus (HPV) L1 virus-like particles or L2 capsid protein elicits neutralizing antibodies that mediate protection. A high-throughput and sensitive in vitro neutralization assay is therefore valuable for prophylactic HPV vaccine studies. Over several hours during infection of the genital tract, virions take on a distinct intermediate conformation, including a required furin cleavage of L2 at its N-terminus. This intermediate is an important target for neutralization by L2-specific antibody, but it is very transiently exposed during in vitro infection of most cell lines resulting in insensitive measurement for L2, but not L1-specific neutralizing antibodies. To model this intermediate, we describe a protocol to generate furin-cleaved HPV pseudovirions (fc-PsV), which deliver an encapsidated reporter plasmid to facilitate infectivity measurements. We also describe a protocol for use of fc-PsV in a high-throughput in vitro neutralization assay for the sensitive measurement of both L1 and L2-specific neutralizing antibodies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Testes de Neutralização / Virossomos / Furina / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Testes de Neutralização / Virossomos / Furina / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article